Neuropathic pain in spinal cord injury: topical analgesics as a possible treatment

Spinal Cord Ser Cases. 2020 Aug 13;6(1):73. doi: 10.1038/s41394-020-00321-1.

Abstract

Study design: Review of the literature and semi-structured interviews.

Objective: To explore the possible use of topical analgesics for the treatment of neuropathic pain (NP) in spinal cord injury (SCI).

Setting: Institute for Neuropathic Pain, Soest, The Netherlands.

Methods: A review was performed of studies on topical analgesics for SCI-related NP published up to May 2019. In addition, eight persons with SCI-related NP who were treated with topical analgesics were interviewed in a semi-structured interview on their experience with topical analgesics.

Results: Seven studies (five case reports and two case series) were found that evaluated the use of topical analgesics for SCI-related NP. None of the studies used a control treatment. Topical analgesics included baclofen, ketamine, lidocaine, capsaicin, and isosorbide dinitrate. All studies reported a decrease in NP over time. Persons interviewed were 49-72 years of age and all but one had an incomplete SCI. They used topical agents containing phenytoin, amitriptyline, baclofen, ketamine or loperamide. All showed a decrease in pain of at least 3 points on the 11-point numeric rating scale during this treatment.

Discussion/conclusions: Evidence on the use of topical analgesics in SCI is scarce. Case reports, case series and interviews suggest that the use of topical analgesics can be beneficial in treating SCI-related NP. Placebo-controlled studies are required to investigate the effect of topical analgesics on SCI-related NP.

Publication types

  • Review

MeSH terms

  • Analgesics / pharmacology*
  • Chronic Pain / drug therapy*
  • Humans
  • Neuralgia / drug therapy*
  • Neuralgia / therapy*
  • Spinal Cord Injuries / complications
  • Spinal Cord Injuries / drug therapy*
  • Treatment Outcome

Substances

  • Analgesics